Evaluating the Impact of CYP3A5 Genotype on Post-Transplant Healthcare Resource Utilization in Pediatric Renal and Heart Transplant Recipients Receiving Tacrolimus

Evaluating the Impact of CYP3A5 Genotype on Post-Transplant Healthcare Resource Utilization in Pediatric Renal and Heart Transplant Recipients Receiving Tacrolimus

Amy L Pasternak,1 Vincent D Marshall,1 Christina L Gersch,2 James M Rae,2 Michael Englesbe,3 Jeong M Park1 1Department of Clinical Pharmacy, University of Michigan College of Pharmacy, Ann Arbor, MI, 48109, USA; 2Department of Internal Medicine, Michigan Medicine, Ann Arbor, MI, 48109, USA; 3Departm...

Full description

Bibliographic Details
Main Authors:	Pasternak AL, Marshall VD, Gersch CL, Rae JM, Englesbe M, Park JM
Format:	Article
Language:	English
Published:	Dove Medical Press 2021-03-01
Series:	Pharmacogenomics and Personalized Medicine
Subjects:	pharmacogenetics cost of care pediatric transplant
Online Access:	https://www.dovepress.com/evaluating-the-impact-of-cyp3a5-genotype-on-post-transplant-healthcare-peer-reviewed-article-PGPM

Similar Items

The Clinical Impact of the C0/D Ratio and the CYP3A5 Genotype on Outcome in Tacrolimus Treated Kidney Transplant Recipients
by: Teun van Gelder, et al.
Published: (2020-07-01)

Genetic Polymorphisms Affecting Tacrolimus Metabolism and the Relationship to Post-Transplant Outcomes in Kidney Transplant Recipients
by: Cheng F, et al.
Published: (2021-11-01)

Impact of Tacrolimus Daily Dose Limitation in Renal Transplant Recipients Expressing CYP3A5: A Retrospective Study
by: Rémi Lenain, et al.
Published: (2021-10-01)

CYP3A5 and UGT1A9 Polymorphisms Influence Immunosuppressive Therapy in Pediatric Kidney Transplant Recipients
by: Paola Krall, et al.
Published: (2021-04-01)

Pharmacogenetics Based Dose Prediction Model for Initial Tacrolimus Dosing in Renal Transplant Recipients
by: Lekshmy Srinivas, et al.
Published: (2021-11-01)

Impact of CYP3A7, CYP2D6 and ABCC2/ABCC3 polymorphisms on tacrolimus steady state concentrations in Bulgarian kidney transplant recipients
by: Tsvetelin Lukanov, et al.
Published: (2022-12-01)

Failure of Achieving Tacrolimus Target Blood Concentration Might Be Avoided by a Wide Genotyping of Transplanted Patients: Evidence from a Retrospective Study
by: Giovanni Pallio, et al.
Published: (2020-06-01)

The Impact of CYP3A4*22 on Tacrolimus Pharmacokinetics and Outcome in Clinical Practice at a Single Kidney Transplant Center
by: Emaad Abdel-Kahaar, et al.
Published: (2019-09-01)

Early impact of donor CYP3A5 genotype and Graft-to-Recipient Weight Ratio on tacrolimus pharmacokinetics in pediatric liver transplant patients
by: Michele Pinon, et al.
Published: (2021-01-01)

CYP3A5 polymorphisms in renal transplant recipients: influence on tacrolimus treatment
by: Chen L, et al.
Published: (2018-03-01)

Personalized tacrolimus dose requirement by CYP3A5 but not ABCB1 or ACE genotyping in both recipient and donor after pediatric liver transplantation.
by: Yi-kuan Chen, et al.
Published: (2014-01-01)

Effect of CYP3A4, CYP3A5, MDR1 and POR Genetic Polymorphisms in Immunosuppressive Treatment in Chilean Kidney Transplanted Patients
by: Stephania Contreras-Castillo, et al.
Published: (2021-12-01)

Pharmacogenetics and drug-induced nephrotoxicity in renal transplant recipients
by: Sepideh Zununi Vahed, et al.
Published: (2015-02-01)

Transplant Recipients Using Tacrolimus Had Higher Utilization of Healthcare Services Than Those Receiving Cyclosporine in Taiwan
by: Yi-Chang Lin, et al.
Published: (2019-09-01)

Limited sampling strategies for estimation of tacrolimus exposure in kidney transplant recipients receiving extended‐release tacrolimus preparation
by: Toqa El‐Nahhas, et al.
Published: (2022-01-01)

CYP3A5 genotype-based model to predict tacrolimus dosage in the early postoperative period after living donor liver transplantation
by: Ji E, et al.
Published: (2018-10-01)

The CYP3A5 genotypes of both liver transplant recipients and donors influence the time‐dependent recovery of tacrolimus clearance during the early stage following transplantation
by: Li Huang, et al.
Published: (2021-10-01)

CYP3A-status is associated with blood concentration and dose-requirement of tacrolimus in heart transplant recipients
by: Máté Déri, et al.
Published: (2021-11-01)

Practice of CYP450 genotyping and phenotyping in children in a real-life setting
by: Frédérique Rodieux, et al.
Published: (2023-02-01)

The impact of CYP3A5 and MDR1 polymorphisms on tacrolimus dosage requirements and trough concentrations in pediatric renal transplant recipients
by: Sireen Shilbayeh, et al.
Published: (2013-01-01)

Commentary: The Clinical Impact of the C0/D Ratio and the CYP3A5 Genotype on Outcome in Tacrolimus Treated Kidney Transplant Recipients
by: Gerold Thölking, et al.
Published: (2021-02-01)

A multi-center interventional study to assess pharmacokinetics, effectiveness, and tolerability of prolonged-release tacrolimus after pediatric kidney transplantation: study protocol for a prospective, open-label, randomized, two-phase, two-sequence, single dose, crossover, phase III b trial
by: Sinem Karaterzi, et al.
Published: (2024-02-01)

Herramientas para un ajuste de dosis de tacrolimus más personalizado en el seguimiento de los pacientes con transplante renal. Fenotipo metabolizador según polimorfismos genéticos del CYP3A vs. el cociente concentración-dosis
by: Anna Vidal-Alabró, et al.
Published: (2024-03-01)

Experience of a Strategy Including CYP2C19 Preemptive Genotyping Followed by Therapeutic Drug Monitoring of Voriconazole in Patients Undergoing Allogenic Hematopoietic Stem Cell Transplantation
by: Irene García-García, et al.
Published: (2021-10-01)

Frequency of CYP3A5 Genetic Polymorphisms and Tacrolimus Pharmacokinetics in Pediatric Liver Transplantation
by: Jefferson Antonio Buendía, et al.
Published: (2020-09-01)

Tacrolimus Pharmacokinetic and Pharmacogenomic Differences between Adults and Pediatric Solid Organ Transplant Recipients
by: Amy Lu, et al.
Published: (2010-09-01)

Genetic polymorphisms of CYP2B6*6, CYP2C8*3 and CYP2D6*4 in vivax malaria patients from Brazilian Amazon
by: José Pereira de Moura Neto, et al.
Published: (2023-11-01)

Tacrolimus monitoring in hair samples of kidney transplant recipients
by: Alexander Born, et al.
Published: (2023-12-01)

The Effects of CYP2C19 Genotype on Proxies of SSRI Antidepressant Response in the UK Biobank
by: Win Lee Edwin Wong, et al.
Published: (2023-09-01)

The prevalence of allelic variants of VKORC1, CYP2C9 and CYP4F2 genes in Zaporizhzhia region population
by: M. Yu. Kolesnik, et al.
Published: (2019-03-01)

Repurposing HLA genotype data of renal transplant patients to prevent severe drug hypersensitivity reactions
by: Lisanne E. N. Manson, et al.
Published: (2023-10-01)

Investigation of clinical interaction between omeprazole and tacrolimus in CYP3A5 non-expressors, renal transplant recipients
by: Paraskevi F Katsakiori, et al.
Published: (2010-06-01)

CYP3A and CYP2C19 activity in urine in relation to CYP3A4, CYP3A5, and CYP2C19 polymorphisms in Russian peptic ulcer patients taking omeprazole
by: Denisenko NP, et al.
Published: (2018-06-01)

Insights into the Pharmacogenetics of Tacrolimus Pharmacokinetics and Pharmacodynamics
by: Mercè Brunet, et al.
Published: (2022-08-01)

CYP2C19 Genotype‐Guided Antiplatelet Therapy After Percutaneous Coronary Intervention in Diverse Clinical Settings
by: Amber L. Beitelshees, et al.
Published: (2022-02-01)

Allelic and genotype frequencies of major CYP2B6 polymorphisms in the Pakistani population
by: Sagheer Ahmed, et al.
Published: (2021-03-01)

An Interdisciplinary Experience focused on Pharmacogenetics: Engaging pharmacy and physician assistant students in conversations about antiplatelet therapy with respect to CYP2C19 genotype
by: Diane M Calinski, et al.
Published: (2016-02-01)

Frequency distribution of polymorphisms of CYP2C19, CYP2C9, VKORC1 and SLCO1B1 genes in the Yakut population
by: Filipp Filippovich Vasilyev, et al.
Published: (2016-01-01)

Pharmacokinetics of apixaban and tacrolimus or cyclosporine in kidney and lung transplant recipients
by: Holly Mansell, et al.
Published: (2022-07-01)

Pharmacokinetics of tacrolimus according to body composition in recipients of kidney transplants
by: Seung Seok Han, et al.
Published: (2012-09-01)